The St. Jude Bone Marrow Transplantation Program performs transplants on newborns, infants, children, adolescents and young adults who have a malignant or non-malignant life-threatening disorders. The program is an active research enterprise with clinical and pre-clinical investigators developing novel therapeutic strategies.
Bone Marrow Tranplantation Experts
-
Stephen Gottschalk, MD
Gottschalk
Stephen Gottschalk, MD, St. Jude Department of Bone Marrow Transplantation & Cellular Therapy chair, focuses his research on cancer immunotherapy, cell therapy and stem cell transplantation. He leads a team of clinical and scientific researchers conducting clinical studies with T cells engineered to target cancer cells, improving those that have been successful for patients with blood cancers, while also developing novel approaches for brain and solid tumors, which have yet to be treated effectively by cellular therapy.
-
Swati Naik, MBBS
Naik
Swati Naik, MBBS, Department of Bone Marrow Transplantation & Cellular Therapy, studies cellular therapies for hematological malignancies and haplo-identical transplants for high-risk hematological malignancy patients. Naik also studies graft manipulation and incorporation of cellular therapies in the transplant platform to maximize the graft’s anti-leukemia effect and minimize infections.
-
Akshay Sharma, MBBS, MSc.
Sharma
Akshay Sharma, MBBS, MSc, St. Jude Department of Bone Marrow Transplantation & Cellular Therapy, coordinates the bone marrow transplantation program for patients with sickle cell disease. Sharma is leading clinical research using gene editing for treating sickle cell disease.
-
Brandon Triplett, MD
Triplett
Brandon Triplett, MD, St. Jude deputy clinical director and Department of Bone Marrow Transplantation & Cellular Therapy member, directs clinical trials that study blood cancers. Triplett’s research interests revolve around the use of hematopoietic cell transplant for high-risk leukemia patients, and the use of alternative mismatched donors (such as parents) in patients who lack a fully matched donor.
